Complete Genomics Posts Q2 Revenue Gains But Misses Estimates

Though the firm fell short of Wall Street estimates, it announced two new contracts worth around $14 million and said that its backlog as of June 30 was around $12 million and 2,200 genomes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories